Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4551]

ASCO 2022: Gut microbiome associated with increased immune cell infiltration in the tumour microenvironment and response to immunotherapy across cancer types

ASCO 2022: Gut microbiome associated with increased immune cell infiltration in the tumour microenvironment and...

ASCO 2022: Gut microbiome signatures associated with immunotherapy response in glioblastoma

ASCO 2022: Gut microbiome signatures associated with immunotherapy response in glioblastoma

Four multinational, interdisciplinary teams selected to address major challenges in cancer

Four multinational, interdisciplinary teams selected to address major challenges in cancer

Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer

Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer

ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple myeloma patients

ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple...

ASCO 2022: Lung cancer therapy could help patients live longer

ASCO 2022: Lung cancer therapy could help patients live longer

Age-related lung changes provide pathway for metastatic growth of dormant melanoma cancer cells

Age-related lung changes provide pathway for metastatic growth of dormant melanoma cancer cells

The paired perils of breast cancer and diabetes

The paired perils of breast cancer and diabetes

Common prostate cancer medications may be less safe than previously thought

Common prostate cancer medications may be less safe than previously thought

DWI for detection of locally recurrent pancreatic cancer

DWI for detection of locally recurrent pancreatic cancer

More from ecancer